Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences Debt to Equity Ratio : 0.7241 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.7241 |
| June 30, 2026 | 0.7645 |
| March 31, 2026 | 0.7261 |
| December 31, 2025 | 0.7408 |
| Date | Value |
|---|---|
| September 30, 2025 | 0.8921 |
| June 30, 2025 | 0.9251 |
| March 31, 2025 | -1.187 |
| December 31, 2024 | -1.531 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Natera, Inc. | 0.1278 |
| Myriad Genetics, Inc. | 0.7784 |
| BioRestorative Therapies, Inc. | 0.0114 |
| CareDx, Inc. | 0.062 |
| Exagen, Inc. | 2.088 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.256B |
| Total Liabilities (Quarterly) | 616.14M |
| Shareholders Equity (Quarterly) | 639.48M |
| Current Ratio | 6.715 |
| Net Debt Paydown Yield | -0.10% |